Factors Affecting Outbound Open Innovation Performance in Bio-Pharmaceutical Industry-Focus on Out-Licensing Deals
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Factors Affecting Outbound Open Innovation Performance in Bio-Pharmaceutical Industry-Focus on Out-Licensing Deals
Authors
Keywords
-
Journal
Sustainability
Volume 13, Issue 8, Pages 4122
Publisher
MDPI AG
Online
2021-04-08
DOI
10.3390/su13084122
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Influence of a Firm’s Capability and Dyadic Relationship of the Knowledge Base on Ambidextrous Innovation in Biopharmaceutical M&As
- (2019) Ye Jin Lee et al. Sustainability
- Open innovation and firm performance: Evidence from the Chinese mechanical manufacturing industry
- (2018) Si Zhang et al. JOURNAL OF ENGINEERING AND TECHNOLOGY MANAGEMENT
- How an Open Innovation Strategy for Commercialization Affects the Firm Performance of Korean Healthcare IT SMEs
- (2018) Hana Kim et al. Sustainability
- Factors Affecting Pricing in Patent Licensing Contracts in the Biopharmaceutical Industry
- (2018) Jeong Lee et al. Sustainability
- Structural Relationship and Influence between Open Innovation Capacities and Performances
- (2018) Kwangsoo Shin et al. Sustainability
- Effect of Distance on Open Innovation: Differences among Institutions According to Patent Citation and Reference
- (2017) JinHyo Yun et al. Sustainability
- The changing model of big pharma: impact of key trends
- (2016) Ajay Gautam et al. DRUG DISCOVERY TODAY
- Models for open innovation in the pharmaceutical industry
- (2013) Alexander Schuhmacher et al. DRUG DISCOVERY TODAY
- The impact of open innovation on firm performance: The moderating effects of internal R&D and environmental turbulence
- (2013) Kuang-Peng Hung et al. TECHNOVATION
- Implementation Steps for Successful Out-Licensing
- (2011) Ulrich Lichtenthaler RESEARCH-TECHNOLOGY MANAGEMENT
- Is open innovation the way forward for big pharma?
- (2010) Jackie Hunter et al. NATURE REVIEWS DRUG DISCOVERY
- How to improve R&D productivity: the pharmaceutical industry's grand challenge
- (2010) Steven M. Paul et al. NATURE REVIEWS DRUG DISCOVERY
- Organisational modes for Open Innovation in the bio-pharmaceutical industry: An exploratory analysis
- (2010) Mattia Bianchi et al. TECHNOVATION
- Choosing between international technology licensing partners: An empirical analysis of U.S. biotechnology firms
- (2009) YoungJun Kim JOURNAL OF ENGINEERING AND TECHNOLOGY MANAGEMENT
- Open Innovation in Practice: An Analysis of Strategic Approaches to Technology Transactions
- (2008) Ulrich Lichtenthaler IEEE TRANSACTIONS ON ENGINEERING MANAGEMENT
- Open innovation in SMEs: Trends, motives and management challenges
- (2008) Vareska van de Vrande et al. TECHNOVATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started